Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting

Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study

(2021) Alexandru Popa et al.   Diagnostics

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Detecting chronic liver disease: are liver function tests the solution?

(2020) Prarthana Thiagarajan et al.   BRITISH JOURNAL OF HOSPITAL MEDICINE

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

NAFLD 2020: The State of the Disease

(2020) Thomas G. Cotter et al.   GASTROENTEROLOGY

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

(2020) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis

(2020) Katsutoshi Sugimoto et al.   RADIOLOGY

Ultrasound-based liver elastography: current results and future perspectives

(2020) Cheng Fang et al.   Abdominal Radiology

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

(2020) Romina Lomonaco et al.   DIABETES CARE

Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis

(2019) Wah-Kheong Chan et al.   Clinical Gastroenterology and Hepatology

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   JOURNAL OF HEPATOLOGY

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

(2019) Milan J Sonneveld et al.   Lancet Gastroenterology & Hepatology

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

(2019) Fernando Bril et al.   DIABETES CARE

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

(2019) Marc G. Ghany et al.   HEPATOLOGY

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

(2018) Zobair M. Younossi et al.   HEPATOLOGY

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

(2018) Paolo Angeli et al.   JOURNAL OF HEPATOLOGY

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

(2018) Vincent Wai-Sun Wong et al.   Nature Reviews Gastroenterology & Hepatology

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2018) Scott M. Grundy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis

(2017) Eva Herrmann et al.   HEPATOLOGY

Response to: Comment to “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”

(2017) Giulio Marchesini et al.   JOURNAL OF HEPATOLOGY

Acoustic Radiation Force Impulse (ARFI) Elastography for non‑invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis

(2017) Xiangdong Hu et al.   Medical Ultrasonography

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

(2016) Masao Omata et al.   Hepatology International

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

(2016) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study

(2015) Nezam H. Afdhal et al.   Clinical Gastroenterology and Hepatology

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

(2015) Paola Dongiovanni et al.   HEPATOLOGY

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015)   JOURNAL OF HEPATOLOGY

Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

(2013) Stuart McPherson et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)

(2010) Francoise Degos et al.   JOURNAL OF HEPATOLOGY

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study

(2010) Jean-Pierre Zarski et al.   LIVER INTERNATIONAL